4811 |
Monitoring of indicators related to TB-HIV |
06/06/2024 |
Surveillance, SM&E and Epidemiology |
4813 |
Monitoring of indicators related to TB-HIV Treatment |
06/06/2024 |
Surveillance, SM&E and Epidemiology |
4815 |
Monitoring of indicators related to TB-HIV prevention |
06/06/2024 |
Surveillance, SM&E and Epidemiology |
4817 |
Monitoring of Tobacco usage in TB patients |
06/06/2024 |
Surveillance, SM&E and Epidemiology |
4819 |
Monitoring of indicators related to DBT |
06/06/2024 |
Surveillance, SM&E and Epidemiology |
4834 |
General Process of Supervision |
06/06/2024 |
Surveillance, SM&E and Epidemiology |
4835 |
Pre-requisites for Supervision |
06/06/2024 |
Surveillance, SM&E and Epidemiology |
4836 |
Planning for Supervisory visit |
06/06/2024 |
Surveillance, SM&E and Epidemiology |
4837 |
Guidelines for Selection of area/health facility for Supervision |
06/06/2024 |
Surveillance, SM&E and Epidemiology |
4838 |
Modalities of Supervision |
06/06/2024 |
Surveillance, SM&E and Epidemiology |
4840 |
Supervisory tools and checklist |
06/06/2024 |
Surveillance, SM&E and Epidemiology |
4868 |
Sub-national Certification |
06/06/2024 |
Surveillance, SM&E and Epidemiology |
4869 |
Level of monitoring |
06/06/2024 |
Surveillance, SM&E and Epidemiology |
4870 |
Protocol for review meetings |
06/06/2024 |
Surveillance, SM&E and Epidemiology |
4874 |
Patient Helpdesk |
06/06/2024 |
Surveillance, SM&E and Epidemiology |
4878 |
Recommended Supervisory Visits |
06/06/2024 |
Surveillance, SM&E and Epidemiology |
4880 |
Joint Supportive Supervision Mission |
06/06/2024 |
Surveillance, SM&E and Epidemiology |
4881 |
Nikshay Data Policy for Monitoring and Review: Outcome |
06/06/2024 |
Surveillance, SM&E and Epidemiology |
4882 |
Nikshay Data Policy for Monitoring and Review |
06/06/2024 |
Surveillance, SM&E and Epidemiology |
4883 |
Review Meeting Protocols- District Level/ Block Level/ Village level |
06/06/2024 |
Surveillance, SM&E and Epidemiology |
4884 |
Review Meeting Protocols- State Level |
06/06/2024 |
Surveillance, SM&E and Epidemiology |
4885 |
Monitoring – Know how’s |
06/06/2024 |
Surveillance, SM&E and Epidemiology |
4886 |
Levels of Monitoring |
06/06/2024 |
Surveillance, SM&E and Epidemiology |
4923 |
Control, Elimination and Eradication |
06/06/2024 |
Surveillance, SM&E and Epidemiology |
4926 |
Pleural TB |
06/06/2024 |
Surveillance, SM&E and Epidemiology |
5043 |
Lymph node Tuberculosis [LNTB] |
06/06/2024 |
Surveillance, SM&E and Epidemiology |
5044 |
Epidemiology of LNTB |
06/06/2024 |
Surveillance, SM&E and Epidemiology |
5045 |
Pathogenesis of LNTB |
06/06/2024 |
Surveillance, SM&E and Epidemiology |
5046 |
Clinical Presentation of LNTB |
06/06/2024 |
Surveillance, SM&E and Epidemiology |
5047 |
Approach to Lymphadenopathy in LNTB |
06/06/2024 |
Surveillance, SM&E and Epidemiology |